121 related articles for article (PubMed ID: 2461869)
1. Restriction fragment length polymorphisms in the ETS-1 proto-oncogene. Comparison of Saudi and Western populations.
Parkar MH; Seid JM; Rowson JM; Stringer BM; Vencer LJ; Aur RJ; Goyns MH
Experientia; 1988 Dec; 44(11-12):1019-20. PubMed ID: 2461869
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
Kerckaert JP; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus MA; Laï JL; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre MH
Leukemia; 1990 Jan; 4(1):16-9. PubMed ID: 1967322
[TBL] [Abstract][Full Text] [Related]
3. Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23.
Savage PD; Hanson CA; Kersey JH
Blood; 1987 Jul; 70(1):327-9. PubMed ID: 2885050
[TBL] [Abstract][Full Text] [Related]
4. Sst I RFLP linked to the human ets-1 gene.
Kerckaert JP; Dozier C; Loucheux-Lefebvre MH; Stehelin D
Nucleic Acids Res; 1987 Jul; 15(14):5905. PubMed ID: 2886980
[No Abstract] [Full Text] [Related]
5. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
Chenevix-Trench G; Southall M; Kidson C
Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
[TBL] [Abstract][Full Text] [Related]
6. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
Koduru PR; Goh JC; Broome JD
Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
[TBL] [Abstract][Full Text] [Related]
7. XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia.
Crossen PE; Morrison MJ
Leukemia; 1992 Aug; 6(8):843-4. PubMed ID: 1353551
[TBL] [Abstract][Full Text] [Related]
8. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S
Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094
[TBL] [Abstract][Full Text] [Related]
9. The oncogene ETS1 is distant from the chromosome 11 breakpoint in leukaemic cells with the t(11;19)(q23;p13).
Kennedy MA; Morris CM; Fitzgerald PH
Leuk Res; 1989; 13(6):459-63. PubMed ID: 2671514
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
12. Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter.
Majérus MA; Bibollet-Ruche F; Telliez JB; Wasylyk B; Bailleul B
Nucleic Acids Res; 1992 Jun; 20(11):2699-703. PubMed ID: 1614856
[TBL] [Abstract][Full Text] [Related]
13. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
Reddy ES; Rao VN
Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
15. A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their families.
Opalka B; Wandl U; Kloke O; Oberle C; Koppe J; Niederle N; Schmidt CG
Blood; 1989 Feb; 73(3):814-7. PubMed ID: 2563665
[TBL] [Abstract][Full Text] [Related]
16. Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies.
Seth A; Watson DK; Fujiwara S; Showalter SD; Papas TS
Oncogene Res; 1989; 5(1):61-6. PubMed ID: 2674859
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
Corell B; Zoll B
FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
[TBL] [Abstract][Full Text] [Related]
18. The ets-1 gene and ataxia telangiectasia.
Concannon P
Immunol Today; 1990 Dec; 11(12):432. PubMed ID: 1981470
[No Abstract] [Full Text] [Related]
19. Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies.
Collyn d'Hooghe M; Galiègue-Zouitina S; Szymiczek D; Lantoine D; Quief S; Loucheux-Lefebvre MH; Kerckaert JP
Leukemia; 1993 Nov; 7(11):1777-85. PubMed ID: 8231246
[TBL] [Abstract][Full Text] [Related]
20. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
